2 results match your criteria: "Nice Sophia University[Affiliation]"
Detection of BRAF p.V600E Mutations in Melanoma by Immunohistochemistry Has a Good Interobserver Reproducibility.
Arch Pathol Lab Med
January 2014
From units EA4340 (Drs Marin, Julié, and Emile) and EA4339 (Drs Beauchet, Zimmermann, and Saiag), Versailles SQY University, Boulogne, France; the Departments of Pathology (Drs Marin, Zimmermann, Julié, and Emile), Public Health (Dr Beauchet), and General and Oncologic Dermatology (Dr Saiag), Ambroise Pare Hospital, APHP, Boulogne, France; the Department of Neuropathology, Ruprecht-Karls-University Heidelberg, and Clinical Cooperation Unit Neuropathology, German Cancer Research Center (DKFZ), Heidelberg, Germany (Drs Capper and Deimling); and the Laboratory of Clinical and Experimental Pathology, Pasteur Hospital and Medical School, Nice Sophia University, Nice, France (Drs Ilie and Hofman).
Context: Assessment of BRAF p.V600E mutational status has become necessary for treatment of patients with metastatic melanoma. Detection of p.
View Article and Find Full Text PDFImmunohistochemistry to identify EGFR mutations or ALK rearrangements in patients with lung adenocarcinoma.
Ann Oncol
July 2012
Laboratory of Clinical and Experimental Pathology, Pasteur Hospital, CHU Nice, and Medical School, Nice Sophia University, Nice, France.
Background: Immunohistochemistry has been proposed as a specific and sensitive method to identify EGFR mutations or ALK rearrangements in lung tumours.
Patients And Methods: We assessed EGFR and KRAS by direct sequencing in 154 patients with lung adenocarcinoma. ALK rearrangements were assayed by FISH and RT-PCR.